Elevance Health (A58) Stock Statistics & Valuation Metrics

Elevance Health has a market cap or net worth of CHF69.02B. The enterprise value is CHF115.45K.

Elevance Health has ― shares outstanding. The number of shares has decreased by -2.65% in one year.

Elevance Health’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 6.65%.

The current PE Ratio of Elevance Health is 17.7. Elevance Health’s PEG ratio is -5.70.

In the last 12 months, Elevance Health had revenue of 199.13B and earned 5.66B in profits. Earnings per share was 25.18.

In the last 12 months, operating cash flow was 7.46B and capital expenditures -1.18B, giving a free cash flow of 6.29B billion.

Elevance Health pays an annual dividend of ―, resulting in a dividend yield of ―

Elevance Health upcoming earnings date is Oct 21, 2026, Before Open (Confirmed).

Elevance Health as a current ratio of 1.24, with Debt / Equity ratio of 69.17%

In the past 12 months, Elevance Health has paid 1.05B in taxes.

Elevance Health EV to EBITDA ratio is 10.51, with an EV/FCF ratio of 31.98.

Elevance Health has CHF37.51B in cash and marketable securities with CHF31.04B in debt, giving a net cash position of CHF6.47B billion.

Gross margin is 38.95%, with operating margin of 4.07%, and net profit margin of 2.84%.

The average price target for Elevance Health is CHF362.47, which is 11.43% higher than the current price. The consensus rating is Moderate Buy